How big is the knee osteoarthritis treatment market?

As for the Europe Knee Osteoarthritis Treatment landscape Germany is projected to reach US million by 2028 trailing a CAGR of over the forecast period.Global Knee Osteoarthritis Treatment Market Insights Forecast to 2028.

Global Knee Osteoarthritis Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Knee Osteoarthritis Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Q: Who are the key players in the knee osteoarthritis treatment market?

Some of the key players are Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Inc., Sanofi, Horizon Therapeutics, Johnson and Johnson, GlaxoSmithKline PLC, Bayer, Abbott, Pfizer Inc, Eli Lilly, Japan, GlaxoSmithKline, Others.

Code: QYRE-Auto-6F3327

Report

January 2023

Pages:111

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint gradual wears away in knee osteoarthritis. The knee joint becomes frayed and rough as the protective space in-between the bones reduces as the cartilage wears off. This causes friction in between the bones, which leads to painful bone spurs. The most common cause of this condition include age, rising weight, inherited abnormalities, repetitive stress injuries, heavy & stressful activities, and other illnesses such as rheumatoid arthritis and metabolic disorders. Symptoms of this conditions include swelling, warmth sensation in the joint, knee stiffness, and decrease in mobility.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Knee Osteoarthritis Treatment estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Knee Osteoarthritis Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Knee Osteoarthritis Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Knee Osteoarthritis Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Knee Osteoarthritis Treatment include Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson and GlaxoSmithKline, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Knee Osteoarthritis Treatment companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Knee Osteoarthritis Treatment market. Further, it explains the major drivers and regional dynamics of the global Knee Osteoarthritis Treatment market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Bioventus

AVM Biotechnology

Anika Therapeutics

Flexion Therapeutics

OrthoTrophix

Sanofi

Horizon Therapeutics

Johnson and Johnson

GlaxoSmithKline

Bayer

Abbott

Pfizer

Eli Lilly

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Knee Osteoarthritis Treatment Segment by Type

Non-surgical Treatment

Surgical Treatment

Knee Osteoarthritis Treatment Segment by Application

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Knee Osteoarthritis Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Knee Osteoarthritis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Knee Osteoarthritis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Knee Osteoarthritis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Knee Osteoarthritis Treatment revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Knee Osteoarthritis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Knee Osteoarthritis Treatment revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson and GlaxoSmithKline, etc.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Non-surgical Treatment

1.2.3 Surgical Treatment

1.3 Market by Application

1.3.1 Global Knee Osteoarthritis Treatment Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Specialty Clinics

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Knee Osteoarthritis Treatment Market Size (2017-2028)

2.2 Knee Osteoarthritis Treatment Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Knee Osteoarthritis Treatment Market Size by Region (2017-2022)

2.4 Global Knee Osteoarthritis Treatment Market Size Forecast by Region (2023-2028)

2.5 Global Top Knee Osteoarthritis Treatment Countries Ranking by Market Size

3 Knee Osteoarthritis Treatment Competitive by Company

3.1 Global Knee Osteoarthritis Treatment Revenue by Players

3.1.1 Global Knee Osteoarthritis Treatment Revenue by Players (2017-2022)

3.1.2 Global Knee Osteoarthritis Treatment Market Share by Players (2017-2022)

3.2 Global Knee Osteoarthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Knee Osteoarthritis Treatment Revenue

3.4 Global Knee Osteoarthritis Treatment Market Concentration Ratio

3.4.1 Global Knee Osteoarthritis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Knee Osteoarthritis Treatment Revenue in 2021

3.5 Global Knee Osteoarthritis Treatment Key Players Head office and Area Served

3.6 Key Players Knee Osteoarthritis Treatment Product Solution and Service

3.7 Date of Enter into Knee Osteoarthritis Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Knee Osteoarthritis Treatment Breakdown Data by Type

4.1 Global Knee Osteoarthritis Treatment Historic Revenue by Type (2017-2022)

4.2 Global Knee Osteoarthritis Treatment Forecasted Revenue by Type (2023-2028)

5 Global Knee Osteoarthritis Treatment Breakdown Data by Application

5.1 Global Knee Osteoarthritis Treatment Historic Market Size by Application (2017-2022)

5.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Knee Osteoarthritis Treatment Revenue by Company (2020-2022)

6.2 North America Knee Osteoarthritis Treatment Revenue by Type (2017-2028)

6.3 North America Knee Osteoarthritis Treatment Revenue by Application (2017-2028)

6.4 North America Knee Osteoarthritis Treatment Revenue by Country (2017-2028)

6.4.1 United States

6.4.2 Canada

7 Europe

7.1 Europe Knee Osteoarthritis Treatment Revenue by Company (2020-2022)

7.2 Europe Knee Osteoarthritis Treatment Revenue by Type (2017-2028)

7.3 Europe Knee Osteoarthritis Treatment Revenue by Application (2017-2028)

7.4 Europe Knee Osteoarthritis Treatment Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8 Asia Pacific

8.1 Asia Pacific Knee Osteoarthritis Treatment Revenue by Company (2020-2022)

8.2 Asia Pacific Knee Osteoarthritis Treatment Revenue by Type (2017-2028)

8.3 Asia Pacific Knee Osteoarthritis Treatment Revenue by Application (2017-2028)

8.4 Asia Pacific Knee Osteoarthritis Treatment Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 China Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

9 Latin America

9.1 Latin America Knee Osteoarthritis Treatment Revenue by Company (2020-2022)

9.2 Latin America Knee Osteoarthritis Treatment Revenue by Type (2017-2028)

9.3 Latin America Knee Osteoarthritis Treatment Revenue by Application (2017-2028)

9.4 Latin America Knee Osteoarthritis Treatment Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Knee Osteoarthritis Treatment Revenue by Company (2020-2022)

10.2 Middle East and Africa Knee Osteoarthritis Treatment Revenue by Type (2017-2028)

10.3 Middle East and Africa Knee Osteoarthritis Treatment Revenue by Application (2017-2028)

10.4 Middle East and Africa Knee Osteoarthritis Treatment Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 UAE

11 Company Profiles

11.1 Bioventus

11.1.1 Bioventus Company Details

11.1.2 Bioventus Business Overview

11.1.3 Bioventus Knee Osteoarthritis Treatment Products and Services

11.1.4 Bioventus Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.1.5 Bioventus Knee Osteoarthritis Treatment SWOT Analysis

11.1.6 Bioventus Recent Developments

11.2 AVM Biotechnology

11.2.1 AVM Biotechnology Company Details

11.2.2 AVM Biotechnology Business Overview

11.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Products and Services

11.2.4 AVM Biotechnology Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.2.5 AVM Biotechnology Knee Osteoarthritis Treatment SWOT Analysis

11.2.6 AVM Biotechnology Recent Developments

11.3 Anika Therapeutics

11.3.1 Anika Therapeutics Company Details

11.3.2 Anika Therapeutics Business Overview

11.3.3 Anika Therapeutics Knee Osteoarthritis Treatment Products and Services

11.3.4 Anika Therapeutics Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.3.5 Anika Therapeutics Knee Osteoarthritis Treatment SWOT Analysis

11.3.6 Anika Therapeutics Recent Developments

11.4 Flexion Therapeutics

11.4.1 Flexion Therapeutics Company Details

11.4.2 Flexion Therapeutics Business Overview

11.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Products and Services

11.4.4 Flexion Therapeutics Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.4.5 Flexion Therapeutics Knee Osteoarthritis Treatment SWOT Analysis

11.4.6 Flexion Therapeutics Recent Developments

11.5 OrthoTrophix

11.5.1 OrthoTrophix Company Details

11.5.2 OrthoTrophix Business Overview

11.5.3 OrthoTrophix Knee Osteoarthritis Treatment Products and Services

11.5.4 OrthoTrophix Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.5.5 OrthoTrophix Knee Osteoarthritis Treatment SWOT Analysis

11.5.6 OrthoTrophix Recent Developments

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Knee Osteoarthritis Treatment Products and Services

11.6.4 Sanofi Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.6.5 Sanofi Knee Osteoarthritis Treatment SWOT Analysis

11.6.6 Sanofi Recent Developments

11.7 Horizon Therapeutics

11.7.1 Horizon Therapeutics Company Details

11.7.2 Horizon Therapeutics Business Overview

11.7.3 Horizon Therapeutics Knee Osteoarthritis Treatment Products and Services

11.7.4 Horizon Therapeutics Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.7.5 Horizon Therapeutics Knee Osteoarthritis Treatment SWOT Analysis

11.7.6 Horizon Therapeutics Recent Developments

11.8 Johnson and Johnson

11.8.1 Johnson and Johnson Company Details

11.8.2 Johnson and Johnson Business Overview

11.8.3 Johnson and Johnson Knee Osteoarthritis Treatment Products and Services

11.8.4 Johnson and Johnson Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.8.5 Johnson and Johnson Knee Osteoarthritis Treatment SWOT Analysis

11.8.6 Johnson and Johnson Recent Developments

11.9 GlaxoSmithKline

11.9.1 GlaxoSmithKline Company Details

11.9.2 GlaxoSmithKline Business Overview

11.9.3 GlaxoSmithKline Knee Osteoarthritis Treatment Products and Services

11.9.4 GlaxoSmithKline Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.9.5 GlaxoSmithKline Knee Osteoarthritis Treatment SWOT Analysis

11.9.6 GlaxoSmithKline Recent Developments

11.10 Bayer

11.10.1 Bayer Company Details

11.10.2 Bayer Business Overview

11.10.3 Bayer Knee Osteoarthritis Treatment Products and Services

11.10.4 Bayer Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.10.5 Bayer Knee Osteoarthritis Treatment SWOT Analysis

11.10.6 Bayer Recent Developments

11.11 Abbott

11.11.1 Abbott Company Details

11.11.2 Abbott Business Overview

11.11.3 Abbott Knee Osteoarthritis Treatment Products and Services

11.11.4 Abbott Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.11.5 Abbott Recent Developments

11.12 Pfizer

11.12.1 Pfizer Company Details

11.12.2 Pfizer Business Overview

11.12.3 Pfizer Knee Osteoarthritis Treatment Products and Services

11.12.4 Pfizer Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.12.5 Pfizer Recent Developments

11.13 Eli Lilly

11.13.1 Eli Lilly Company Details

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Knee Osteoarthritis Treatment Products and Services

11.13.4 Eli Lilly Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022)

11.13.5 Eli Lilly Recent Developments

12 Knee Osteoarthritis Treatment Market Dynamics

12.1 Knee Osteoarthritis Treatment Market Trends

12.2 Knee Osteoarthritis Treatment Market Drivers

12.3 Knee Osteoarthritis Treatment Market Challenges

12.4 Knee Osteoarthritis Treatment Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Non-surgical Treatment

Table 3. Key Players of Surgical Treatment

Table 4. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 5. Global Knee Osteoarthritis Treatment Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

Table 6. Global Knee Osteoarthritis Treatment Revenue by Region (2017-2022) & (US$ Million)

Table 7. Global Knee Osteoarthritis Treatment Revenue Market Share by Region (2017-2022)

Table 8. Global Knee Osteoarthritis Treatment Revenue by Players (2017-2022) & (US$ Million)

Table 9. Global Knee Osteoarthritis Treatment Market Share by Players (2017-2022)

Table 10. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2021)

Table 11. Ranking of Global Top Knee Osteoarthritis Treatment Companies by Revenue (US$ Million) in 2021

Table 12. Global 5 Largest Players Market Share by Knee Osteoarthritis Treatment Revenue (CR5 and HHI) & (2017-2022)

Table 13. Key Players Headquarters and Area Served

Table 14. Key Players Knee Osteoarthritis Treatment Product Solution and Service

Table 15. Date of Key Manufacturers Enter into Knee Osteoarthritis Treatment Market

Table 16. Mergers & Acquisitions, Expansion Plans

Table 17. Global Knee Osteoarthritis Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 18. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2017-2022)

Table 19. Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 20. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2023-2028)

Table 21. Global Knee Osteoarthritis Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 22. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2017-2022)

Table 23. Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 24. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2023-2028)

Table 25. North America Knee Osteoarthritis Treatment Revenue by Company (2020-2022) & (US$ Million)

Table 26. North America Knee Osteoarthritis Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 27. North America Knee Osteoarthritis Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 28. North America Knee Osteoarthritis Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 29. North America Knee Osteoarthritis Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 30. North America Knee Osteoarthritis Treatment Revenue by Country (2017-2022) & (US$ Million)

Table 31. North America Knee Osteoarthritis Treatment Revenue by Country (2023-2028) & (US$ Million)

Table 32. Europe Knee Osteoarthritis Treatment Revenue by Company (2020-2022) & (US$ Million)

Table 33. Europe Knee Osteoarthritis Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 34. Europe Knee Osteoarthritis Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 35. Europe Knee Osteoarthritis Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 36. Europe Knee Osteoarthritis Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 37. Europe Knee Osteoarthritis Treatment Revenue by Country (2017-2022) & (US$ Million)

Table 38. Europe Knee Osteoarthritis Treatment Revenue by Country (2023-2028) & (US$ Million)

Table 39. Asia Pacific Knee Osteoarthritis Treatment Revenue by Company (2020-2022) & (US$ Million)

Table 40. Asia Pacific Knee Osteoarthritis Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 41. Asia Pacific Knee Osteoarthritis Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 42. Asia Pacific Knee Osteoarthritis Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 43. Asia Pacific Knee Osteoarthritis Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 44. Asia Pacific Knee Osteoarthritis Treatment Revenue by Region (2017-2022) & (US$ Million)

Table 45. Asia Pacific Knee Osteoarthritis Treatment Revenue by Region (2023-2028) & (US$ Million)

Table 46. Latin America Knee Osteoarthritis Treatment Revenue by Company (2020-2022) & (US$ Million)

Table 47. Latin America Knee Osteoarthritis Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 48. Latin America Knee Osteoarthritis Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 49. Latin America Knee Osteoarthritis Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 50. Latin America Knee Osteoarthritis Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 51. Latin America Knee Osteoarthritis Treatment Revenue by Country (2017-2022) & (US$ Million)

Table 52. Latin America Knee Osteoarthritis Treatment Revenue by Country (2023-2028) & (US$ Million)

Table 53. Middle East and Africa Knee Osteoarthritis Treatment Revenue by Company (2020-2022) & (US$ Million)

Table 54. Middle East and Africa Knee Osteoarthritis Treatment Revenue by Type (2017-2022) & (US$ Million)

Table 55. Middle East and Africa Knee Osteoarthritis Treatment Revenue by Type (2023-2028) & (US$ Million)

Table 56. Middle East and Africa Knee Osteoarthritis Treatment Revenue by Application (2017-2022) & (US$ Million)

Table 57. Middle East and Africa Knee Osteoarthritis Treatment Revenue by Application (2023-2028) & (US$ Million)

Table 58. Middle East and Africa Knee Osteoarthritis Treatment Revenue by Country (2017-2022) & (US$ Million)

Table 59. Middle East and Africa Knee Osteoarthritis Treatment Revenue by Country (2023-2028) & (US$ Million)

Table 60. Bioventus Company Details

Table 61. Bioventus Business Overview

Table 62. Bioventus Knee Osteoarthritis Treatment Product and Services

Table 63. Bioventus Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 64. Bioventus Knee Osteoarthritis Treatment SWOT Analysis

Table 65. Bioventus Recent Developments

Table 66. AVM Biotechnology Company Details

Table 67. AVM Biotechnology Business Overview

Table 68. AVM Biotechnology Knee Osteoarthritis Treatment Product and Services

Table 69. AVM Biotechnology Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 70. AVM Biotechnology Knee Osteoarthritis Treatment SWOT Analysis

Table 71. AVM Biotechnology Recent Developments

Table 72. Anika Therapeutics Company Details

Table 73. Anika Therapeutics Business Overview

Table 74. Anika Therapeutics Knee Osteoarthritis Treatment Product and Services

Table 75. Anika Therapeutics Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 76. Anika Therapeutics Knee Osteoarthritis Treatment SWOT Analysis

Table 77. Anika Therapeutics Recent Developments

Table 78. Flexion Therapeutics Company Details

Table 79. Flexion Therapeutics Business Overview

Table 80. Flexion Therapeutics Knee Osteoarthritis Treatment Product and Services

Table 81. Flexion Therapeutics Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 82. Flexion Therapeutics Knee Osteoarthritis Treatment SWOT Analysis

Table 83. Flexion Therapeutics Recent Developments

Table 84. OrthoTrophix Company Details

Table 85. OrthoTrophix Business Overview

Table 86. OrthoTrophix Knee Osteoarthritis Treatment Product and Services

Table 87. OrthoTrophix Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 88. OrthoTrophix Knee Osteoarthritis Treatment SWOT Analysis

Table 89. OrthoTrophix Recent Developments

Table 90. Sanofi Company Details

Table 91. Sanofi Business Overview

Table 92. Sanofi Knee Osteoarthritis Treatment Product and Services

Table 93. Sanofi Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 94. Sanofi Knee Osteoarthritis Treatment SWOT Analysis

Table 95. Sanofi Recent Developments

Table 96. Horizon Therapeutics Company Details

Table 97. Horizon Therapeutics Business Overview

Table 98. Horizon Therapeutics Knee Osteoarthritis Treatment Product and Services

Table 99. Horizon Therapeutics Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 100. Horizon Therapeutics Knee Osteoarthritis Treatment SWOT Analysis

Table 101. Horizon Therapeutics Recent Developments

Table 102. Johnson and Johnson Company Details

Table 103. Johnson and Johnson Business Overview

Table 104. Johnson and Johnson Knee Osteoarthritis Treatment Product and Services

Table 105. Johnson and Johnson Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 106. Johnson and Johnson Knee Osteoarthritis Treatment SWOT Analysis

Table 107. Johnson and Johnson Recent Developments

Table 108. GlaxoSmithKline Company Details

Table 109. GlaxoSmithKline Business Overview

Table 110. GlaxoSmithKline Knee Osteoarthritis Treatment Product and Services

Table 111. GlaxoSmithKline Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 112. GlaxoSmithKline Knee Osteoarthritis Treatment SWOT Analysis

Table 113. GlaxoSmithKline Recent Developments

Table 114. Bayer Company Details

Table 115. Bayer Business Overview

Table 116. Bayer Knee Osteoarthritis Treatment Product and Services

Table 117. Bayer Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 118. Bayer Knee Osteoarthritis Treatment SWOT Analysis

Table 119. Bayer Recent Developments

Table 120. Abbott Company Details

Table 121. Abbott Business Overview

Table 122. Abbott Knee Osteoarthritis Treatment Product and Services

Table 123. Abbott Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 124. Abbott Recent Developments

Table 125. Pfizer Company Details

Table 126. Pfizer Business Overview

Table 127. Pfizer Knee Osteoarthritis Treatment Product and Services

Table 128. Pfizer Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 129. Pfizer Recent Developments

Table 130. Eli Lilly Company Details

Table 131. Eli Lilly Business Overview

Table 132. Eli Lilly Knee Osteoarthritis Treatment Product and Services

Table 133. Eli Lilly Knee Osteoarthritis Treatment Revenue in Knee Osteoarthritis Treatment Business (2017-2022) & (US$ Million)

Table 134. Eli Lilly Recent Developments

Table 135. Knee Osteoarthritis Treatment Market Trends

Table 136. Knee Osteoarthritis Treatment Market Drivers

Table 137. Knee Osteoarthritis Treatment Market Challenges

Table 138. Knee Osteoarthritis Treatment Market Restraints

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Knee Osteoarthritis Treatment Sales Market Share by Type: 2021 VS 2028

Figure 2. Non-surgical Treatment Features

Figure 3. Surgical Treatment Features

Figure 4. Global Knee Osteoarthritis Treatment Sales Market Share by Application: 2021 VS 2028

Figure 5. Hospitals Case Studies

Figure 6. Ambulatory Surgical Centers Case Studies

Figure 7. Specialty Clinics Case Studies

Figure 8. Others Case Studies

Figure 9. Knee Osteoarthritis Treatment Report Years Considered

Figure 10. Global Knee Osteoarthritis Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Knee Osteoarthritis Treatment Market Size 2017-2028 (US$ Million)

Figure 12. Global Knee Osteoarthritis Treatment Market Size Market Share by Region: 2021 VS 2028

Figure 13. Global Knee Osteoarthritis Treatment Revenue Market Share by Region in 2017 VS 2022

Figure 14. Global Top 10 Knee Osteoarthritis Treatment Countries Ranking by Market Size (US$ Million) in 2021

Figure 15. Global Knee Osteoarthritis Treatment Market Share by Players in 2021

Figure 16. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2021)

Figure 17. The Top 10 and 5 Players Market Share by Knee Osteoarthritis Treatment Revenue in 2021

Figure 18. North America Knee Osteoarthritis Treatment Revenue Market Share by Company in 2021

Figure 19. North America Knee Osteoarthritis Treatment Revenue Market Share by Type (2017-2028)

Figure 20. North America Knee Osteoarthritis Treatment Revenue Market Share by Application (2017-2028)

Figure 21. North America Knee Osteoarthritis Treatment Revenue Share by Country (2017-2028)

Figure 22. United States Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 23. Canada Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 24. Europe Knee Osteoarthritis Treatment Revenue Market Share by Company in 2021

Figure 25. Europe Knee Osteoarthritis Treatment Revenue Market Share by Type (2017-2028)

Figure 26. Europe Knee Osteoarthritis Treatment Revenue Market Share by Application (2017-2028)

Figure 27. Europe Knee Osteoarthritis Treatment Revenue Share by Country (2017-2028)

Figure 28. Germany Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 29. France Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 30. U.K. Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 31. Italy Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 32. Russia Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 33. Asia Pacific Knee Osteoarthritis Treatment Revenue Market Share by Company in 2021

Figure 34. Asia Pacific Knee Osteoarthritis Treatment Revenue Market Share by Type (2017-2028)

Figure 35. Asia Pacific Knee Osteoarthritis Treatment Revenue Market Share by Application (2017-2028)

Figure 36. Asia Pacific Knee Osteoarthritis Treatment Revenue Share by Region (2017-2028)

Figure 37. China Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 38. Japan Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 39. South Korea Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 40. India Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 41. Australia Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 42. China Taiwan Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 43. Indonesia Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 44. Thailand Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 45. Malaysia Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 46. Latin America Knee Osteoarthritis Treatment Revenue Market Share by Company in 2021

Figure 47. Latin America Knee Osteoarthritis Treatment Revenue Market Share by Type (2017-2028)

Figure 48. Latin America Knee Osteoarthritis Treatment Revenue Market Share by Application (2017-2028)

Figure 49. Latin America Knee Osteoarthritis Treatment Revenue Share by Country (2017-2028)

Figure 50. Mexico Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 51. Brazil Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 52. Argentina Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 53. Middle East and Africa Knee Osteoarthritis Treatment Revenue Market Share by Company in 2021

Figure 54. Middle East and Africa Knee Osteoarthritis Treatment Revenue Market Share by Type (2017-2028)

Figure 55. Middle East and Africa Knee Osteoarthritis Treatment Revenue Market Share by Application (2017-2028)

Figure 56. Middle East and Africa Knee Osteoarthritis Treatment Revenue Share by Country (2017-2028)

Figure 57. Turkey Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 58. Saudi Arabia Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 59. UAE Knee Osteoarthritis Treatment Revenue (2017-2028) & (US$ Million)

Figure 60. Bioventus Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 61. AVM Biotechnology Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 62. Anika Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 63. Flexion Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 64. OrthoTrophix Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 65. Sanofi Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 66. Horizon Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 67. Johnson and Johnson Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 68. GlaxoSmithKline Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 69. Bayer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 70. Abbott Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 71. Pfizer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 72. Eli Lilly Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2017-2022)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5600

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Viscosupplementation for Knee Osteoarthritis Market

Knee Osteoarthritis Treatment Market

Osteoarthritis Pain Market

Osteoarthritis Drugs Market

Osteoarthritis Medications Market

Hip Replacement Market

Rheumatology Therapeutics Market

Total Hip Replacement Market

Psoriatic Arthritis Therapeutics Market

Digital Therapeutics Market

Global Knee Osteoarthritis Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published Date: January 2023

Report Code: QYRE-Auto-6F3327

Global Knee Osteoarthritis Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

FEATURED COMPANIES

Knee Osteoarthritis Treatment Segment by Type

Knee Osteoarthritis Treatment Segment by Application

FEATURED COMPANIES